DJIA 18,069.73 -10.41 -0.06%
NASDAQ 5,070.81 -21.28 -0.42%
S&P 500 2,115.17 -2.52 -0.12%
market minute promo

CLOVIS ONCOLOGY INC (NASDAQ: CLVS)

85.23 -6.80 (-7.39%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CLVS $84.79 -7.87%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $92.19
Previous Close $92.03
Daily Range $85.07 - $92.19
52-Week Range $35.33 - $94.88
Market Cap $2.9B
P/E Ratio -19.50
Dividend (Yield) $0.00 (0.0%)
Volume 374,093
Average Daily Volume 705,444
Current FY EPS -$7.55

Sector

Industry

CLOVIS ONCOLOGY INC (CLVS) Description

Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring developing and commercializing innovative anti-cancer agents in the United States Europe and additional international markets. Website: http://www.clovisoncology.com/

News & Commentary Rss Feed

Why Clovis Oncology, Inc. Is Soaring Higher Today

A key Wall Street upgrade sent shares in Clovis Oncology, Inc. higher today.

Clovis Oncology (CLVS) Falls: Stock Goes Down 5.3% - Tale of the Tape

J.P. Morgan's 3 Biotechnology Picks

Monday's ETF Movers: XBI, GDXJ

Clovis Oncology (CLVS) Stock Spikes Today on Analyst Upgrade

Benzinga's Volume Movers

Top Analyst Upgrades and Downgrades: Apple, BP, Hewlett-Packard, Philip Morris, UnitedHealth, AT&T a

Top Analyst Upgrades and Downgrades: Apple, BP, Hewlett-Packard, Philip Morris, UnitedHealth, AT&T and More

Benzinga's Top #PreMarket Gainers

Clovis Oncology (CLVS) in Focus: Stock Moves 8% Higher - Tale of the Tape

Clovis Oncology's Rucaparib Gets Breakthrough Status - Analyst Blog

See More CLVS News...